Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells (Q47559179)

3 February 2018

review article

1 reference

title

Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells (English)

1 reference

3 February 2018

1 reference

1 reference

Peter Bannasch

1 reference

3 February 2018

Silvia Ribback

series ordinal

1 reference

3 February 2018

Qin Su

series ordinal

1 reference

3 February 2018

Doris Mayer

series ordinal

1 reference

3 February 2018

publication date

1 December 2017

1 reference

3 February 2018

Hepatobiliary & Pancreatic Diseases International

published in

1 reference

3 February 2018

volume

1 reference

3 February 2018

issue

1 reference

3 February 2018

page(s)

570-594

1 reference

3 February 2018

Primary liver cancer: worldwide incidence and trends

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Primary malignant tumors of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell carcinoma of liver. An ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

A clinico-pathologic study of clear-cell hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatic neoformations

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hypoglycemia associated with lipid accumulation in primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatic adenoma.Biochemical and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Histologic prognostic indicators in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Histopathologic features of hepatocellular carcinoma in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clinicopathologic study on clear cell hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clinicopathological and prognostic features of primary clear cell carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Therapy and prognostic features of primary clear cell carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Risk Factors, Prognosis, and Management of Early and Late Intrahepatic Recurrence After Resection of Primary Clear Cell Carcinoma of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Relevance of hepatic preneoplasia for human hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell and non-clear cell hepatocellular carcinoma: a case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground-glass cells in chronic human and woodchuck hepadnaviral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Synchronous renal cell carcinoma and clear cell hepatocellular carcinoma mimicking metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: histological, histochemical and microbiochemical characterization of the novel variant

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Preneoplastic lesions in human hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Primary clear cell carcinoma of noncirrhotic liver: immunohistochemical discrimination of hepatocellular and cholangiocellular origin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

A case of primary clear cell hepatocellular carcinoma in a non-cirrhotic liver: an immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell hepatocellular carcinoma: Back to the basics for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell papillary carcinoma of the liver: An unusual variant of peripheral cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell cholangiocarcinoma of the liver is a morphologically distinctive entity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

A case of intrahepatic clear cell cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Fine-needle aspiration cytomorphology of clear-cell hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clear cell hepatocellular carcinoma diagnosed by bile duct brushing cytology.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Toxicity and Carcinogenicity of Dichlorodiphenyltrichloroethane (DDT).

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Phenotypic instability in focal and nodular lesions induced in a short term system in the rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Metabolism Disrupting Chemicals and Metabolic Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogen storage disease I and hepatocellular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type I

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Nature of early appearing, carcinogen-induced liver lesions to iron accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Primary liver carcinoma arising in people younger than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular Carcinoma in Noncirrhotic Liver with Glycogenotic Foci: Basic Science Meets Genomic Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular carcinoma occurring in a young Crohn's disease patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular carcinoma occurring in a Crohn's disease patient

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Focal hepatic glycogenosis associated with metastatic insulinoma presenting as mass lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Focal glycogenosis of the liver in disorders of ureagenesis: Its occurrence and diagnostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Cytoplasmic Hepatitis B Surface Antigen and the Ground-glass Appearance in Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Ground glasslike hepatocytes produced by glycogen-membrane complexes ("glycogen bodies")

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Liver glycogen bodies: ground-glass hepatocytes in transplanted patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogen pseudoground glass change in hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Oxyphilic granular hepatocytes. Mitochondrion-rich liver cells in hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatic Oncocytes: Incidence, Staining Characteristics, and Ultrastructural Features

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Characteristic upregulation of glucose-regulated protein 78 in an early lesion negative for hitherto established cytochemical markers in rat hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Loss of adenylate cyclase activity in preneoplastic and neoplastic lesions induced in rat liver by N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Cytochemical and biochemical studies on adenylate cyclase activity in preneoplastic and neoplastic liver tissue and cultured liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Biochemical microanalysis of alpha-glucosidase activity in preneoplastic and neoplastic hepatic lesions induced in rats by N-nitrosomorpholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Post-translational regulation of glucose-6-phosphate dehydrogenase activity in (pre)neoplastic lesions in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrosomorpholine

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL- ethionine-supplemented diet

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Pyruvate kinase type M2 and its role in tumor growth and spreading

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Elevation of Glucose-6-Phosphate in Early Stages of Hepatocarcinogenesis Induced in Rats by N-Nitrosomorpholine

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Demonstration of a metabolically active glucose-6-phosphate pool in the lumen of liver microsomal vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Keratin 8/18 regulation of glucose metabolism in normal versus cancerous hepatic cells through differential modulation of hexokinase status and insulin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Impact of keratin intermediate filaments on insulin-mediated glucose metabolism regulation in the liver and disease association

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Differential pathways of insulin action upon the hepatitis B surface antigen gene expression and cell proliferation in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Excess risk of primary liver cancer in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

1 reference

7 January 2021

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Diabetes and Cancer: a Review of Current Knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

ENLARGEMENT OF THE LIVER IN DIABETES MELLITUS

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogen storage in the liver in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Enhancement of hepatocarcinogenesis in rats by dietary fructose

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Behavior of liver enzymes in hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Enzymology of cancer cells (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Enzymology of cancer cells (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

The metabolism of rat liver during carcinogenesis by butter yellow

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

[CHANGES IN METABOLIC PARAMETERS AND GLYCOLYTIC ENZYME ACTIVITIES DURING THE CANCERIZATION OF RAT LIVERS BY DIETHYLNITROSAMINE]

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hepatitis B virus surface antigen interacts with acid alpha-glucosidase and alters glycogen metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hexokinase expression in liver preneoplasia and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

PPARγ contributes to PKM2 and HK2 expression in fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Microheterogeneity of cytosolic and membrane-bound hexokinase II in Morris hepatoma 3924A.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

p53 and metabolism: Inside the TIGAR.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hypoglycemia in primary carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Over-expression of facilitative glucose transporter genes in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

GLUT1 as a therapeutic target in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Recent advances in understanding the cellular roles of GSK-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

GSK-3 as potential target for therapeutic intervention in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Wnt signaling: complexity at the surface.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

GSK-3 - at the crossroads of cell death and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2817%2960071-7

7 January 2021

10.1016/S1499-3872(17)60071-7

Identifiers

DOI

1 reference

3 February 2018

1 reference

3 February 2018